Awake intubation under sedation using target-controlled infusion of dexmedetomidine: five case reports
- 6 July 2010
- journal article
- case report
- Published by Springer Nature in Journal of Anesthesia
- Vol. 24 (5) , 789-792
Abstract
We used target-controlled infusion (TCI) of dexmedetomidine (DEX) for awake intubation under sedation in 5 patients who had a risk of pulmonary aspiration or difficult airway. Dexmedetomidine level was escalated stepwise until the patients developed tolerance to laryngoscopy. The target DEX concentrations at the time of intubation were 2.10–5.95 ng/ml and were higher than those clinically used for sedation in the intensive care unit (ICU). Chin lift was applied in 1 case, and therefore no assisted ventilation was required and pulse oxygen saturation was maintained at >98% throughout the procedure. Simple pharmacological interventions for blood pressure changes induced by increased target plasma DEX concentrations were needed in 4 cases. However, hemodynamics was stable, and no cardiovascular drug was needed after tracheal intubation. Conditions at laryngoscopy were excellent in all cases, and conditions at tracheal intubation were good except in 1 case. Reflex to intubation was preserved in all cases, and coughing was observed in all cases. The patients had no memory of discomfort and/or intubation. Although further investigations are needed, this method may be useful for awake intubation under sedation.Keywords
This publication has 8 references indexed in Scilit:
- The Dose of Succinylcholine Required for Excellent Endotracheal Intubating ConditionsAnesthesia & Analgesia, 2006
- Dexmedetomidine as a Total Intravenous Anesthetic AgentAnesthesiology, 2004
- Dexmedetomidine infusion for sedation during fiberoptic intubation: a report of three casesJournal of Clinical Anesthesia, 2004
- Clinical Uses of α2-Adrenergic AgonistsAnesthesiology, 2000
- The Effects of Increasing Plasma Concentrations of Dexmedetomidine in HumansAnesthesiology, 2000
- Computer-controlled Infusion of Intravenous Dexmedetomidine Hydrochloride in Adult Human VolunteersAnesthesiology, 1993
- Assessment of the Sedative Effects of Dexmedetomidine, an α2‐Adrenoceptor Agonist, with Analysis of Saccadic Eye MovementsBasic & Clinical Pharmacology & Toxicology, 1991
- Controlled Sedation with Alphaxalone-AlphadoloneBMJ, 1974